M3dicine launches Stethee ‘ smart ’ stethoscope

Intelligent medical device developer M3dicine yesterday announced the launch of its Stethee AI-enabled stethoscope system designed to amplify, filter, record and analyze heart and lung sound. The newly launched, FDA-cleared Stethee Pro features technology to capture and analyze heart and lung sounds and data via Bluetooth, operating around smartphone applications for both Apple iOS and Google Android devices, the Brisbane, Australia-based company said. “The Stethee system has the potential to transform healthcare. We are on the forefront of a new era in healthcare driven by artificial intelligence and its ability to significantly improve our ability to care for patients. This innovative technology can significantly help drive efficiency and productivity and empower healthcare providers worldwide by providing real time data and clinical interpretation,” Dr. John Sperling of the Mayo Clinic said in a press release. The Stethee system features the company’s Aida artificial intelligence engine designed to analyze heart and lung sounds to create personal biometric signals. The system is also designed to geo-tag the data, and include environmental data to samples it collects and analyzes. Sound and data from the device is designed to stream to bluetooth enable audio devices or wired headphones, the company said. M3dicine said it has inked an exclusive agreement with Korea Telecom for the distribution of its Stethee Pro in a number of developing countries. “T...
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News Diagnostics m3dicine Source Type: news

Related Links:

Conclusions: In patients with FIP, PVR is a significant contributor of 6MWD, independently from the extent of fibrosis on HRCT. These results strengthen both the rationale to use 6MWD as endpoint in FIP and to target APH with specific therapies.Respiration
Source: Respiration - Category: Respiratory Medicine Source Type: research
Jack Palmer, of Kansas City, Missouri, became the 20th infant under a year old to undergo a heart-lung transplant after he was born in January with a congenital heart defect.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
We report that the disruption of excitation-contraction coupling contributes to impaired force generation in the mouse model of Sod1 deficiency. Briefly, we found a significant reduction in sarcoplasmic reticulum Ca2+ ATPase (SERCA) activity as well as reduced expression of proteins involved in calcium release and force generation. Another potential factor involved in EC uncoupling in Sod1-/- mice is oxidative damage to proteins involved in the contractile response. In summary, this study provides strong support for the coupling between increased oxidative stress and disruption of cellular excitation contraction mac...
Source: Fight Aging! - Category: Research Authors: Tags: Newsletters Source Type: blogs
With the development of medical technology, transplantation has prevailed and become an important tool in the treatment of disease. According to the WHO ’s statistics, as of 2015, approximately 120000 cases of solid organ transplantation have been performed globally. Renal transplantation is the most common, followed by liver transplantation, heart transplantation, lung transplantation, hematopoietic stem cell transplantation, etc. [1]. And, in re cipients of transplantation, seizures usually occur during the postoperative period [2,3].
Source: Seizure: European Journal of Epilepsy - Category: Neurology Authors: Tags: Review Source Type: research
This thirty-fifth adult lung and heart –lung transplant report summarizes data from 64,803 adult lung and 4,054 adult heart-lung transplants performed through June 30, 2017 and reported to the International Thoracic Organ Transplant Registry. With each year's report we now also provide more detailed analyses on a particular focus theme . Since 2013, these have been donor and recipient age; retransplantation; early graft failure; indication for transplant; and allograft ischemic time; and in 2018, multiorgan transplantation.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Tags: Original Clinical Science Source Type: research
Models of power delivery within an intact organism have been limited to ionizing radiation and to some extent sound&magnetic waves for diagnostic purposes. Traditional electrical power delivery within intact human body relies on implanted batteries that limit the amount and duration of delivered power. The efficiency of current battery technology limits substantial demand to be met; such as continuous operation of an implantable artificial heart pump within a human body.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Tags: Original Pre-Clinical Science Source Type: research
This study aimed to evaluate the impact of agonal time and warm ischemic time on early survival in Category III donation after circulatory death (DCD) donor lung transplants (LTx) using data reported to the International Society for Heart and Lung Transplantation (ISHLT) DCD LTx Registry.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Tags: Original Clinical Science Source Type: research
The majority of children supported with ventricular assist devices (VAD) are bridged to heart transplantation. Although bridge to recovery has been reported, low recovery patient numbers has precluded systematic analysis. The aim of this study was to delineate recovery rates, predictors of recovery, and to report the long-term follow-up after VAD explantation in children.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Tags: Original Clinical Science Source Type: research
The past year has been notable for multiple celebrations and symposia around the globe commemorating the first heart transplant performed worldwide by Dr. Christiaan Barnard at Groote Schuur Hospital in Cape Town, South Africa, on December 3, 1967, and the first heart transplant performed in the United States by Dr. Norman Shumway at Stanford Hospital on January 6, 1968. Since then, the field of heart transplantation has grown dramatically, with steady increases in the number of heart transplants performed worldwide annually, accompanied by improvement in post-transplant survival and other favorable outcomes.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Tags: Original Clinical Science Source Type: research
In a recently published article, Asleh et al. demonstrated that cardiac allograft recipients with a baseline serum urate higher than 7 mg/dL are at a two-fold higher risk for developing cardiac allograft vasculopathy (CAV) and that the increase in serum urate during follow-up is associated with plaque progression independently of renal function, sirolimus therapy, and other comorbidities. Εven though there are data about the role of urate in endothelial dysfunction and inflammation, the authors conclude that although serum urate may be a reliable biomarker for CAV progression, its implication in the pathogenesis of...
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Tags: Case Anecdotes, Comments and Opinions Source Type: research
More News: Australia Health | Cardiology | Environmental Health | Heart | Heart Transplant | Learning | Lung Transplant | Medical Devices | Rural Health | Universities & Medical Training